1. New Biogen data showed no major safety issues for its Alzheimer's drug — Lilly puts its oncology future in Lox’s hands — Sage Therapeutics depression drug fails phase 3 trial — See more on our front page news

    TRY TWO WEEKS OF OUR EMAIL NEWS HEADLINES FOR FREE
    Dismiss Notice
  2. Think you have witnessed fraud?Ask a Whistleblower Attorney -- a chance to discuss whistleblower-related legal issues with practicing whistleblower attorneys.
    Dismiss Notice

GE Healthcare

Anonymous board for GE Healthcare


Sort By:
Title
Replies Views
Last Message ↓
  1. anonymous
    Replies:
    0
    Views:
    207
  2. Anonymous
    Replies:
    15
    Views:
    7,743
  3. Anonymous
    Replies:
    4
    Views:
    4,130
  4. Anonymous
    Replies:
    2
    Views:
    3,272
  5. Anonymous
    Replies:
    10
    Views:
    7,684
  6. anonymous
    Replies:
    0
    Views:
    494
  7. anonymous
    Replies:
    3
    Views:
    2,930
  8. anonymous
    Replies:
    1
    Views:
    2,223
  9. Anonymous
    Replies:
    1
    Views:
    3,307
  10. anonymous
    Replies:
    0
    Views:
    624
  11. anonymous
    Replies:
    3
    Views:
    2,045
  12. anonymous
    Replies:
    0
    Views:
    878
  13. Anonymous
    Replies:
    54
    Views:
    23,416
  14. anonymous
    Replies:
    9
    Views:
    5,158
  15. anonymous
    Replies:
    10
    Views:
    4,378
  16. Anonymous
    Replies:
    31
    Views:
    14,526
  17. anonymous
    Replies:
    0
    Views:
    1,499
  18. anonymous
    Replies:
    3
    Views:
    2,546
  19. anonymous
    Replies:
    0
    Views:
    1,535
  20. anonymous
    Replies:
    7
    Views:
    3,744

Thread Display Options

Loading...